Documenta Ophthalmologica

, Volume 95, Issue 2, pp 157–164 | Cite as

Demyelination of retinal myelinated nerve fibers in Behcet's disease

  • Pamela S. Chavis
  • Khalid F. Tabbara


A 39 year-old Behcet's patient had demyelination of retinal myelinated nerve fibers after recurrent papillitis and vitritis. Oral Prednisolone, cyclosporine, and later periocular corticosteroids and oral colchicine were used but demyelination continued over a 5 year-period. A pseudobulbar palsy with urinary incontinence and pyramidal tract signs developed and azathioprine and corticosteroids were used. Demyelination of retinal nerve fibers stopped and while treatment was underway, the central nervous system (CNS) signs were stable. While the ocular pathology of Behcet's can mirror the CNS signs, indeed optic nerve ischemic demyelination may signal the potential for CNS involvement; azathioprine with prednisone may be more effective in the long-term for optic nerve and CNS involvement than cyclosporine with prednisone.

Behcet's CNS demyelination retinal nerve fibers 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Miller NR. Myelinated (medullated) nerve fibers. In: Walsh and Hoyt's Clinical neuro-ophthalmology Vol 1 4th ed. Baltimore: Williams & Wilkins, 1982: 367–9.Google Scholar
  2. 2.
    Schachat AP, Miller NR. Atrophy of myelinated retinal nerve fibers after acute optic neuropathy. Am J Ophthalmol 1981; 92: 854–6.PubMedGoogle Scholar
  3. 3.
    Sharpe JA, Sanders MD. Atrophy of myelinated nerve fibers in the retina in optic neuritis. Br J Ophthalmol 1975; 59: 229–32.PubMedGoogle Scholar
  4. 4.
    Barra C, Belfort JR, Abreu MT, Kim MK, Martins MC, Petrilli AM. Behcet's disease in Brazil-a review of 49 cases with emphasis on ophthalmic manifestations. Jpn J Ophthalmol 1991; 35: 339–46.PubMedGoogle Scholar
  5. 5.
    Cotticelli L, Apponi-Battii G, Federico A, Cotrufo R, Annunziata P, Dilorio G. Behcet's disease: an unusual case with bilateral obliterating retinal panarteritis and ischemic optic atrophy. Ophthalmologica 1980; 180: 328–32.PubMedCrossRefGoogle Scholar
  6. 6.
    Kansu T, Kirkali P, Kanzu E, Zileli T. Optic neuropathy in Behcet's disease. J Clin Neuro Ophthalmol 1989; 9(4): 277–80.Google Scholar
  7. 7.
    Colvard DM, Robertson DM, O'Duffy ID. The ocular manifestations of Behcet's disease. Arch Ophthalmol 1977; 95: 1813–7.PubMedGoogle Scholar
  8. 8.
    Mullaney J, Collum LM. Ocular vasculitis in Behcet's disease. A pathological and immunohistochemical study. Int Ophthalmol 1985; 7: 183–91.PubMedCrossRefGoogle Scholar
  9. 9.
    Charteris DG, Barton K, McCartney AC, Lightman SL. CD4+ lymphocyte involvement in ocular Behcet's disease. Autoimmunity 1991; 12(3): 201.Google Scholar
  10. 10.
    Hartung HP, Schafer B, Fierz W, Heiinger K, Toyka KV. Cyclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat. Neurosci Lett 1987; 83: 195–200.PubMedCrossRefGoogle Scholar
  11. 11.
    O'Duffy JD, Goldstein NP. Neurologic involvement in seven patients with Behcet's disease. Am J Med 1976; 61: 170.PubMedCrossRefGoogle Scholar
  12. 12.
    Johnson KP, Belendiuk G. Use of cyclosporine in neurological autoimmune disease? [editorial]. Arch Neurol 1985; 42: 1043–4.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Pamela S. Chavis
    • 1
  • Khalid F. Tabbara
    • 2
  1. 1.The Eye Center (The Eye Foundation for Research in OphthalmologyKing Khaled Eye Specialist HospitalSaudi Arabia
  2. 2.Department of Ophthalmology, College of MedicineKing Saud University The Eye Center (The Eye Foundation for Research in OphthalmologySaudi Arabia

Personalised recommendations